FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/08/020923 [Registered on: 27/08/2019] Trial Registered Prospectively
Last Modified On: 05/12/2019
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A study which determines if Dexamethasone reduces vomiting after laproscopic gall bladder removal surgery. 
Scientific Title of Study   A STUDY TO EVALUATE THE ROLE OF DEXAMETHASONE IN PROPHYLAXIS OF POST OPERATIVE NAUSEA AND VOMITING IN LAPROSCOPIC CHOLECYSTECTOMY 
Trial Acronym  Dexamethasone In PONV 
Secondary IDs if Any    
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Tarang Jain 
Designation  Assistant Professor 
Affiliation  ESI PGIMSR  
Address  ESI PGIMSR Basaidarapur new delhi
Basaidarapur New Delhi
North West
DELHI
110015
India 
Phone  98111827264  
Fax    
Email  dr.tarang@yahoo.co.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Tarang Jain 
Designation  Assistant Professor 
Affiliation  ESI PGIMSR  
Address  ESI PGIMSR Basaidarapur new delhi
Basaidarapur New Delhi
North West
DELHI
110015
India 
Phone  98111827264  
Fax    
Email  dr.tarang@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Dr Tarang Jain 
Designation  Assistant Professor 
Affiliation  ESI PGIMSR  
Address  ESI PGIMSR Basaidarapur new delhi
Basaidarapur New Delhi
North West
DELHI
110015
India 
Phone  98111827264  
Fax    
Email  dr.tarang@yahoo.co.in  
 
Source of Monetary or Material Support  
ESI PGIMSR BASAIDARAPUR 
 
Primary Sponsor  
Name  ESI PGIMSR  
Address  Basaidarapur New Delhi 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Tarang Jain  ESI PGIMSR   Room No 4, Second Floor OT Block Department of Anaesthesiology, Basaidarapur
West
DELHI 
98111827264

dr.tarang@yahoo.co.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Comittee, ESI PGIMSR Basaidarapur  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K802||Calculus of gallbladder without cholecystitis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Dexamethasone  Dexamethasone is given to patients at the beginning of the surgery to determine the incidence of post operative nausea and vomiting 
Comparator Agent  Ondensetron  This is used as the comparator agent in determining the incidence of post operative nausea and vomiting 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  1. ASA Class 1-2
2. Patients undergoing elective laproscopic cholecystectomy
 
 
ExclusionCriteria 
Details  1. Patient refusal
2. Patients who are pregnant or who have uncontrolled diabetes, glaucoma (all patients had blood glucose concentrations checked to exclude undiagnosed hyperglycaemia).
3. Those with a known adverse reaction to dexamethasone or who were taking any systemic steroids (excluding steroid inhalers, suppositories, pessaries, eye drops, one-off local injections to a joint, or topical preparations) were excluded from the trial. 4. Patients previously taking regular oral or intravenous steroids had to have stopped taking these drugs at least three months before trial entry to be eligible.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Pre-numbered or coded identical Containers 
Blinding/Masking   Participant, Investigator and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
To determine if there any difference in post operative Nausea nad Vomiting when Dexamethasone is used in elective laproscopic cholecystectomy under general anaesthesia  0, 2, 6, 12 and 24 hours post operatively 
 
Secondary Outcome  
Outcome  TimePoints 
• To determine difference in intra operative pain by using hemodynamic parameters

• To determine difference in post operative pain by using the Visual Analogue Scale.

• To determine difference in incidence of post operative sore throat.
 
Hemodynamic parameters shall be recorded every 15 minutes intra operatively.

0 hour, 2 hour, 6 hour, 12 hour and 24 hours post operative 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "150"
Final Enrollment numbers achieved (India)="150" 
Phase of Trial   N/A 
Date of First Enrollment (India)   02/09/2019 
Date of Study Completion (India) 30/09/2019 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   Long is among the most common complications after surgery, affecting more than 30% of patients. It is reported by patients to be among the top five undesirable outcomes. A systematic review has shown laproscopic surgery and increasing duration of surgery as independent predictors of PONV. Dexamethasone is a corticosteroid that influences patient outcome. It has been assesed in prevention of PONV in intermediate and low risk surgery. Post operative pain is a main reason for delayed discharge. Opiods are ttraditionally used for acute post operative pain relief but can lead to side effects like nausea and vomiting and itching. Co analgesic drugs reduce the amount of opiods needed. Dexamethasone has been evaluated as a co analgesic due to it`s anti inflammatory effect as well as effect on pain pathway. We aim to asses the effect of Dexamethasone on post operative nausea and vomiting and post operative pain medicine requirement. 
Close